03/14/2021 7:34 PM
Clarín.com
World
Updated 03/14/2021 7:34 PM
The Netherlands this Sunday joined the European countries that suspended "as a precaution" the use of the AstraZeneca vaccine against the coronavirus.
The pharmaceutical company assured that
"there is no evidence" that their coronavirus vaccine causes an increased risk of blood clots
despite the decision of several countries to suspend its use as a precautionary measure, reported in a statement.
The company made this statement after having carried out "
a careful review" of the data available
on those who received the vaccine in the United Kingdom and the European Union (EU).
"Some
17 million people in the EU and UK have already received our vaccine
and the number of clot cases reported among this group is lower than the average that can be expected in the general population," he explained. the pharmacist through a statement signed by its chief physician, Ann Taylor.
News in development
AFG
